Raymond James lowered the firm’s price target on Johnson & Johnson to $165 from $170 and keeps an Outperform rating on the shares.
Analyst Tim Anderson of Bank of America Securities reiterated a Hold rating on Johnson & Johnson (JNJ – Research Report), reducing the ...
The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback